Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BBWI
BBWI logo

BBWI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Bath & Body Works Inc (BBWI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
19.630
1 Day change
-4.52%
52 Week Range
33.960
Analysis Updated At
2026/06/18
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Bath & Body Works Inc (BBWI) is not a strong buy at this time for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the company has shown some positive developments, such as a strong dividend payout and a 74% increase in net income, the declining sales figures, mixed analyst ratings, and lack of strong trading signals suggest that this is not an optimal entry point. The stock's turnaround story is still developing, and there is limited visibility into its success in the near term.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. The RSI is neutral at 69.542, and moving averages are converging, showing no strong trend. Key resistance levels are at $21.084 and $22.129, while support levels are at $19.391 and $17.699.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
2
Buy
8

Positive Catalysts

  • The return of the semi-annual sale with discounts up to 75% has driven recent stock gains.

  • Dividend payout of $0.20 per share reflects strong financial health.

  • Net income increased by 74% year-over-year in Q1.

Neutral/Negative Catalysts

  • Net sales declined by 3% year-over-year in Q

  • Analysts have lowered price targets due to macroeconomic concerns and inflationary pressures.

  • Limited visibility into the company's turnaround strategy and innovation expected only in the second half of 2026.

Financial Performance

In Q1, net income rose 74% year-over-year to $183 million, but net sales fell 3% from $1.424 billion to $1.378 billion. The company has reaffirmed its FY26 guidance despite a weak consumer sentiment backdrop.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have mixed views. Recent price target changes range from $19 to $25, with ratings varying from Neutral to Buy. Analysts are cautiously optimistic about the company's turnaround story but note ongoing challenges in body care sales and macroeconomic pressures.

Wall Street analysts forecast BBWI stock price to rise
14 Analyst Rating
Wall Street analysts forecast BBWI stock price to rise
4 Buy
10 Hold
0 Sell
Moderate Buy
Current: 19.630
sliders
Low
15
Averages
20.14
High
26
Current: 19.630
sliders
Low
15
Averages
20.14
High
26
Wells Fargo
Overweight
maintain
$25 -> $26
AI Analysis
2026-06-23
New
Reason
Wells Fargo
Price Target
$25 -> $26
AI Analysis
2026-06-23
New
maintain
Overweight
Reason
Wells Fargo raised the firm's price target on Bath & Body Works to $26 from $25 and keeps an Overweight rating on the shares. Although bearish investors remain focused on low-single-digit core growth and limited visibility into future innovation, near-term channel checks suggest new product launches and innovation arriving in July could quickly improve sentiment and change the narrative, the analyst says in a research note.
Goldman Sachs
Neutral
downgrade
$26 -> $23
2026-06-01
Reason
Goldman Sachs
Price Target
$26 -> $23
2026-06-01
downgrade
Neutral
Reason
Goldman Sachs lowered the firm's price target on Bath & Body Works to $23 from $26 and keeps a Neutral rating on the shares. Body care sales fell in the mid-teens due to assortment and space constraints from collaborations and a pullback on underperforming Everyday Luxuries, with management noting the category remains strong and expects innovation, marketing shifts, and improved core offerings to support a return to growth by 2027, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BBWI
Unlock Now

People Also Watch